Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Legalon SIL for HCV Recurrence After Liver Transplant
NCT01535092Phase 2Terminated
- Sponsor
- Rottapharm Biotech
- Start
- Sep 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Legalon SIL in hepatitis C (HCV), sponsored by Rottapharm Biotech. Started Sep 2010; status: terminated.
02
Drugs
Legalon SIL
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01535092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535092.